31-May-2019 | Zion Market Research
Zion Market Research has published a new report titled “Molecular Diagnostics Market by Product & Services (Reagents and Kits, Instruments, and Software and Services), by Application (Genetic Tests, Infectious Diseases, Oncology, and Others), by Technology (PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarrays, and Others), and by End-User (Diagnostic Laboratories, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018–2025”. According to the report, the global molecular diagnostics market was approximately USD 8.02 billion in 2018 and is expected to generate around USD 14.56 billion by 2025, at a CAGR of around 8.9% between 2019 and 2025.
Molecular diagnostics includes the molecular biology techniques that are used for the detection of biomarkers present in genomes or proteomes. In molecular diagnostic techniques, molecular biology techniques are used for medical testing purpose. The growing incidence of infectious diseases and cancer is increasing the demand for molecular diagnostics techniques. The rapid advancements witnessed in the molecular biology technologies, development of molecular diagnostic technologies to automated processes, growing awareness about molecular diagnostics usage for the detection of different diseases in developing countries, and increasing government funding for research in molecular biology are driving the global molecular diagnostics market. However, the high cost of technologies and the lack of a skilled workforce to handle the instruments are hindering the global molecular diagnostics market growth.
Browse the full “Molecular Diagnostics Market by Product & Services (Reagents and Kits, Instruments, and Software and Services), by Application (Genetic Tests, Infectious Diseases, Oncology, and Others), by Technology (PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarrays, and Others), and by End-User (Diagnostic Laboratories, Hospitals, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/molecular-diagnostics-market
The molecular diagnostics market is fragmented into product and services, application, technology, and end-user. Based on product and services, the molecular diagnostics market includes instruments, reagents and kits, and software and services. Reagents and kits are projected to dominate the market in the future, owing to the rising use of various reagents in different therapeutic areas, easy availability of a wide range of kits and reagents, and increasing R&D activities related to molecular diagnostics.
The application segment of the molecular diagnostics market includes genetic tests, infectious diseases (HIV, hepatitis, HPV, CT/NG, influenza, TB, and others), oncology (life breast cancer, lung cancer, colorectal cancer, prostate cancer, and other cancers), and others. The infectious diseases segment dominated the global molecular diagnostics market in 2018, due to the growing prevalence of infectious diseases and raising awareness about the use of molecular diagnostic technology.
Based on technology, the market is fragmented into DNA microarrays, DNA sequencing and NGS, polymerase chain reaction, in situ hybridization, isothermal nucleic acid amplification technology, and others. The polymerase chain reaction segment is predicted to dominate the market in the years ahead, owing to the rising use of PCR in genomics and proteomics research and rapid advancements and automation of the PCR technology.
The end-user segment comprises diagnostic laboratories, hospitals, and others. Hospitals dominated the end-user segment in 2018, owing to the increase in the number of diagnostics tests conducted in hospitals.
By region, North America dominated the market in 2018, owing to the early introduction of highly developed equipment for research activities, the presence of highly skilled workforce, and an increase in the number of projects for the development of new molecular diagnostic technologies. The Asia Pacific molecular diagnostics market is anticipated to show the highest year-to-year growth in the upcoming years, due to the rising investments by government and leading companies for R&D, high prevalence of infectious diseases in the developing countries of China and India, and growing awareness about molecular diagnostics usage for different disease detection.
Some major players of the global molecular diagnostics market are Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Novartis, Johnson and Johnson, bioMerieux, Bio-Rad Laboratories, Qiagen NV, Siemens Healthcare, Danaher Corporation, and Hologic.
This report segments the global molecular diagnostics market into:
Global Molecular Diagnostics Market: Product and Services Analysis
Global Molecular Diagnostics Market: Application Analysis
Global Molecular Diagnostics Market: Technology Analysis
Global Molecular Diagnostics Market: End-User Analysis
Global Molecular Diagnostics Market: Regional Analysis
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651